Robot model
Myomo MyoPro
Powered (motor-actuated) upper-limb orthosis controlled by the user's own EMG (myoelectric) muscle signals: faint bicep/tricep signals trigger powered…
- Manufacturer
- Myomo
- Form factor
- exoskeleton
- Maturity
- commercial
- Lifecycle
- active
- Website
- myomo.com ↗
Overview
Powered (motor-actuated) upper-limb orthosis controlled by the user's own EMG (myoelectric) muscle signals: faint bicep/tricep signals trigger powered elbow/hand assistance for people with arm paralysis. FDA 510(k) cleared (K062631). Powered, user-EMG-controlled.
Verified vs. claimed
- Maturity stage
- commercial(Commercially deployed with revenue-generating operations.)
- Verified deployments
- None on file
- Sources on file
- 2 sources, view all
No verified deployments on file. DEPLOY tracks independently-sourced deployment evidence separately from manufacturer capability claims.
Key facts
Robot
Focus
Origin
Founded
CEO
Product
Listed on
Application
Specs
Use
Control
Powered
Regulatory
Body region
Availability
Data & sources
Web sources
2
2 sources backing this record.View all →
Pricing
No verified price is on record for Myomo MyoPro. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
Myomo MyoPro on the deployment map
Where Myomo MyoPro is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Verified media addedVerifiedJun 11, 2026
Myomo MyoPro device for stroke arm recovery
- Record createdJun 6, 2026
Added to the verified registry
Safety record
No incidents on record for Myomo MyoPro.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (2)
Common questions
- What is Myomo MyoPro?
- Powered (motor-actuated) upper-limb orthosis controlled by the user's own EMG (myoelectric) muscle signals: faint bicep/tricep signals trigger powered elbow/hand assistance for people with arm paralysis. FDA 510(k) cleared (K062631). Powered, user-EMG-controlled.
- How much does Myomo MyoPro cost?
- Myomo MyoPro's price is not publicly disclosed. DEPLOY has no verified price on record for Myomo MyoPro from Myomo. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
- Is Myomo MyoPro actually deployed in the real world?
- Myomo MyoPro is recorded at the commercial stage, but DEPLOY has no deployment verified at a named site yet; vendor deployment claims are not independently confirmed here. Manufacturer capability claims should be read as claims pending independent verification.
- Who makes Myomo MyoPro?
- Myomo MyoPro is made by Myomo, based in Boston, Massachusetts, USA, founded in 2004.
- Can you buy Myomo MyoPro?
- Myomo MyoPro is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
- What are alternatives to Myomo MyoPro?
- On the DEPLOY registry, comparable exoskeleton robots to Myomo MyoPro include German Bionic Cray X, Cyberdyne HAL, EksoNR, ReWalk 7.
- How does Myomo MyoPro compare to German Bionic Cray X?
- Myomo MyoPro and German Bionic Cray X (German Bionic · 5 deployments) are both exoskeleton robots on the DEPLOY registry. Myomo MyoPro has 0 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
- Is Myomo MyoPro a top exoskeleton?
- On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Myomo MyoPro ranks in roughly the top 93% of exoskeleton models tracked by the registry.
- What is Myomo MyoPro's maturity stage?
- Myomo MyoPro is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
- Where is Myomo MyoPro deployed?
- No verified deployments of Myomo MyoPro are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.
- Is Myomo MyoPro safe?
- Myomo MyoPro has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 2 sources (no primary) · last reviewed 2026-07-08
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-07-08
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: exoskeleton
Sources by quality tier
- 2
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Myomo MyoPro.Recent coverage
Myomo MyoPro in third-party press
Myomo and Elevance Health Agree to Contract for Multi-State Network Participation - Business Wire
Myomo launches MyoPro 2x, enhancing independence for patients with arm and hand paralysis - Medical Economics
Myomo to raise $6M with eyes on Medicare coverage - MassDevice
Attention vs reality over time
Media mentions per month (area) against verified deployment events (dots). A press spike over a flat deployment line is the hype gap, drawn over time.
In the press
Recent coverage mentioning Myomo MyoPro from third-party publications. Automatically surfaced; not part of the verified registry record.
Myomo and Elevance Health Agree to Contract for Multi-State Network Participation - Business Wire
<a…
Myomo launches MyoPro 2x, enhancing independence for patients with arm and hand paralysis - Medical Economics
<a…
Myomo to raise $6M with eyes on Medicare coverage - MassDevice
<a…
Myomo prices $4.4M offering, scores reimbursement win - MassDevice
<a…
Myomo prices $6.5M public offering - MassDevice
<a…
Myomo touts independent study of its MyoPro myoelectric orthosis - MassDevice
<a…
Myomo scales up production, training for MyoPro device for upper-body mobility - The Robot Report
<a…
High-tech device helps young man compensate for arm injury - Akron Beacon Journal
<a…
MyoPro the Assistive Arm Exoskeleton by Myomo Featured in SolidWorks - Exoskeleton Report
<a…
Machine-readable surfaces
- Markdown mirror: /models/myomo-myopro.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/9a6f03e0-9428-40a7-b0ad-cf8c85071e85
- Revision history: /models/myomo-myopro/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Reality vs attention
Myomo MyoPro draws attention at the 37th percentile but verifies reality at the insufficient-data level among exoskeletons.
6-month trend
Analysis
Thin deployment record; scale validation still in progress.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Jul 23, 2026